DAFNA Capital Management LLC
Top Portfolio Positions
79 positions ·
$382,680,155 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
580,678 | $56,470,935 | 14.76% | |
| STXS |
Stereotaxis, Inc.
Healthcare
|
13,680,554 | $25,172,219 | 6.58% | |
| DAWN |
Day One Biopharmaceuticals, Inc.
Healthcare
|
978,463 | $20,978,246 | 5.48% | |
| ATRC |
AtriCure, Inc.
Healthcare
|
597,431 | $17,044,706 | 4.45% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
476,740 | $15,884,976 | 4.15% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
250,772 | $14,582,391 | 3.81% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
217,497 | $14,335,227 | 3.75% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
2,418,882 | $13,376,417 | 3.50% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
165,178 | $11,884,557 | 3.11% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
443,829 | $9,586,706 | 2.51% |
Portfolio Trend
25 quarters · across all stocks
Holdings in SNDX
Shares Held
Position Value (USD)
24 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,077,412 | 217,355 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,837,733 | 277,855 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,703,300 | 500,702 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,090,832 | 543,602 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,689,207 | 544,502 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,165,266 | 542,002 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,139,013 | 526,702 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,489,729 | 657,074 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $15,697,861 | 659,574 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $16,047,024 | 742,574 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,655,575 | 458,373 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,436,771 | 450,873 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,442,181 | 447,073 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $11,378,007 | 447,073 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,542,352 | 355,487 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,137,789 | 370,987 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,465,134 | 371,987 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,491,151 | 296,535 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,542,215 | 80,702 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,536,043 | 147,702 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,285,700 | 57,500 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $222,400 | 10,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,516,043 | 102,713 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,335,200 | 360,000 | Shares | Sole | 2020-08-14 | |
| No 13F history on record for this holder in this stock. | ||||||